Vermilion Life Sciences Ltd
Stuart is Chair of the Advisory Committee on Clinical Excellence Awards (ACCEA). He is a fully GMC registered physician, who trained in General Medicine and General Practice before gaining many years’ experience in senior leadership roles at Roche, GlaxoSmithKline, Norgine, Takeda and UCB. He is the Founder of Vermilion Life Sciences, which provides consultancy services to reduce the time and cost of medicines development to improve patient access.
Stuart is also an Authority Member of the Human Tissue Authority, a Board Trustee of the Faculty of Pharmaceutical Medicine, and has worked as an external ‘Champion'' for the UK Government''s Office for Life Sciences, Accelerated Access Review.
Reengineering Medicines Development
Exploring opportunities to reduce the cost and time of medicines development. How patient input, digital tools and real world data in real time can facilitate adaptive licensing and early regulator and payer discussions to generate early access.
EVEN MORE SEMINARS
Laura Allington University College London Hospitals NHS Foundation Trust
Operational challenges of planning a new NHS high energy proton service.
Mani Naghibi St. Mark's Hospital
Using nutrition therapies to positively effect cancer treatment outcomes
Stéfan Halbherr InnoMedica
Liposome pipeline addressing unmet medical needs in oncology, imaging, and neurodegeneration
Sanjay P Prabhu Boston Children’s Hospital & Harvard Medical School
Evolving role of machine learning in brain tumour imaging
Sam Janes UCL
Early Detection of Lung Cancer